corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 6576

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

SmithKline Beecham claims Halfan is “effective in all types of malaria” and has an “excellent safety profile”
MaLAM International News 1995 Mar; 13:(3):1-2


Abstract:

SmithKline Beecham is promoting Halfan in Pakistan as a first-line therapy for malaria despite the fact that it is much more expensive than chloroquine and that chloroquine resistance is still very low.

Keywords:
*analysis/Pakistan/developing countries/SmithKline Beecham/Halfan/malaria/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend